| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 86.35▲ | 86.90▼ | 87.92▼ | 92.21▼ | 83.56▲ |
| MA10 | 86.18▲ | 88.66▼ | 89.78▼ | 89.48▼ | 77.16▲ |
| MA20 | 86.45▲ | 89.88▼ | 89.81▼ | 82.32▲ | 62.00▲ |
| MA50 | 88.08▼ | 91.12▼ | 92.89▼ | 75.90▲ | 47.75▲ |
| MA100 | 89.98▼ | 92.33▼ | 85.97▲ | 60.31▲ | 31.79▲ |
| MA200 | 89.79▼ | 85.25▲ | 79.43▲ | 52.57▲ | 28.33▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.166▲ | -0.462▼ | -0.413▼ | 0.364▲ | 2.230▲ |
| RSI | 47.427▼ | 34.854▼ | 36.997▼ | 56.761▲ | 68.823▲ |
| STOCH | 70.192 | 8.493▼ | 22.751 | 50.963 | 79.679 |
| WILL %R | -10.265▲ | -84.775▼ | -84.775▼ | -62.342 | -29.398 |
| CCI | 171.245▲ | -100.364▼ | -159.166▼ | 23.239 | 114.384▲ |
| MA | $NKTR Price Crossed Below MA(13) | Set Alert |
|
Saturday, April 25, 2026 08:26 AM
Nektar Therapeutics (NASDAQ:NKTR) presented 52-week top-line results from a 16-week blinded treatment extension of its Phase 2b REZOLVE-AA study evaluating rezpegaldesleukin (rezpeg) in adults with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/04/26 | 92.06 | 94.32 | 85.39 | 86.775 | 1,494,206 |
| 24/04/26 | 91.88 | 92.06 | 88.69 | 91.68 | 921,250 |
| 23/04/26 | 93.59 | 95.21 | 87.3701 | 91.26 | 2,051,164 |
| 22/04/26 | 95.45 | 98.39 | 93.02 | 93.20 | 3,622,140 |
| 21/04/26 | 103.00 | 106.42 | 96.23 | 98.16 | 1,561,608 |
| 20/04/26 | 97.30 | 109.00 | 95.77 | 100.35 | 4,747,083 |
| 17/04/26 | 85.39 | 86.95 | 84.15 | 84.86 | 509,820 |
| 16/04/26 | 83.26 | 84.63 | 80.535 | 83.99 | 623,403 |
| 15/04/26 | 81.76 | 83.70 | 81.395 | 83.22 | 527,498 |
| 14/04/26 | 80.65 | 81.43 | 78.12 | 81.26 | 523,680 |
|
|
||||
|
|
||||
|
|